David Y. Jackson - Concepedia

Author

David Y. Jackson

Juvaris BioTherapeutics (United States)

Also Known As

David Jackson, David Y. Jackson

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Juvaris BioTherapeutics (United States)University of California, Santa Barbara

About

David Y. Jackson is an author at Juvaris BioTherapeutics (United States) specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1K
2	Natural Sciences	11	11	1.2K
3	Biochemistry	10	10	1.1K
4	Engineering	5	5	498
5	Health Sciences	1	1	24

David Y. Jackson

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
General approach to the synthesis of short .alpha.-helical peptides David Y. Jackson, David S. King, Jean Chmielewski, Journal of the American Chemical Society Chemical AnalysisBiochemistryDonut IconNatural SciencesPeptide Library	1991	308
A Designed Peptide Ligase for Total Synthesis of Ribonuclease A with Unnatural Catalytic Residues David Y. Jackson, John P. Burnier, Clifford Quan, Science Bioorganic ChemistryEngineeringEngineered VariantPeptide EngineeringMolecular Biology	1994	284
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity Shelley E. Ackerman, Cecelia I. Pearson, Joshua D. Gregorio, Nature Cancer Tumor ImmunologyCancer ImmunosurveillanceImmunologyTumor ImmunityAutoimmunity	2020	194
Antibody–Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs Christopher R. Behrens, Edward Ha, Lawrence Chinn, Molecular Pharmaceutics Afford AdcsImmunologyImmunotherapeuticsChemical BiologyOther Pharmacological Properties	2015	150
An Improved Preparation of (+)2,3-O-Isopropylidene-D-Glyceraldehyde David Y. Jackson Synthetic Communications EngineeringBiochemistryMultigram ScaleNatural SciencesGlycobiology	1988	94
Potent α4β1 Peptide Antagonists as Potential Anti-Inflammatory Agents David Y. Jackson, Clifford Quan, Dean R. Artis, Journal of Medicinal Chemistry Cell AdhesionImmune RegulationImmunologyPeptide ScienceImmune System	1997	80
Enzymic Cyclization of Linear Peptide Esters Using Subtiligase David Y. Jackson, John P. Burnier, James Wells Journal of the American Chemical Society Medicinal ChemistryBiosynthesisBioorganic ChemistryMolecular SciencesBiochemistry	1995	80
Processes for Constructing Homogeneous Antibody Drug Conjugates David Y. Jackson Organic Process Research & Development Medicinal ChemistryBiochemistryHomogeneous AdcsDrug DiscoveryNatural Sciences	2016	76
Enantioselective formation of functionalized 1,3-disubstituted allenes: synthesis of .alpha.-allenic .omega.-carbomethoxy alcohols of high optical purity Owen W. Gooding, Colin C. Beard, David Y. Jackson, The Journal of Organic Chemistry Enantioselective SynthesisNatural SciencesDiversity-oriented SynthesisFunctionalized 1,3-Disubstituted AllenesAltmetric Attention Score	1991	69
Activation Parameters and Stereochemistry of an Antibody‐Catalyzed Claisen Rearrangement David Y. Jackson, Michael N. Liang, Paul A. Bartlett, Angewandte Chemie International Edition in English Antibody CatalysisBiochemistryChorismate–prephenate Conversion 1Natural SciencesEnzyme Catalysis	1992	53

Page 1